The additional scrutiny applied to certain class III implantable devices and class IIb active devices intended to administer or remove a medicinal product, in which an expert panel may review the notified body’s assessment of the clinical evaluation before certification.
Reference: MDR Article 54 and Annex IX Section 5.1